Dermatology Reports (Mar 2022)

Immunohistochemical expression of interleukin 1 beta in papule biopsies from patients with acne vulgaris

  • Le Thai Van Thanh,
  • Le Vi Anh,
  • Tran Huong Giang,
  • Ta Quoc Hung,
  • Van The Trung,
  • Nguyen Lam Vuong

DOI
https://doi.org/10.4081/dr.2022.9444

Abstract

Read online

Background: Acne vulgaris is the most common inflammatory disease of the skin. IL-1b has been found in acne lesions and is a promising target for therapy, but the evidence is limited. Therefore, this study was conducted to investigate the immunohistochemical expression of IL-1b in papule biopsies of inflammatory acne and its association with disease severity. Methods: This study involved 20 patients with acne vulgaris (13 females, median age: 22 years). Samples were taken using punch biopsy. Immunohistochemical IL-1b expression was semiquantitatively assessed as absent, mild, moderate or strong. Disease severity was evaluated according to the Global Acne Grading System (GAGS). Results: There were 7 patients with mild disease and 11 patients with moderate disease. Median GAGS score was 20. Mild and moderate accounted for 65% and 30% for dermal IL-1b expression, 60% and 40% for epidermal expression, and 70% and 15% for perifollicular expression. Moderatestrong perifollicular expression had significant higher GAGS score than absent-mild expression (median: 22 versus 16). Conclusions: This study shows the elevated immunoreactivity of IL-1b in papule biopsies of inflammatory acne vulgaris. The levels of IL-1b expression also correlates with disease severity. IL- 1b could be a good candidate for targeting treatment of acne vulgaris.

Keywords